Table 1.
Lipid Panel Variables: Fold Change from Baseline over Time among On-Treatment A5260s Subjects with Viral Suppression and No ART Interruption
| Baseline (n=234) | ALL subjects (n=234) Mean Fold Change (95% CI) |
||
|---|---|---|---|
| Biomarker | Mean (95% CI) | 24 wk | 96 wk |
| Total cholesterol (mg/dl) | 154.40 (150.00, 158.80) | 1.04 (1.01, 1.07) | 1.07 (1.04, 1.10) |
| HDL (mg/dl) | 37.80 (36.30, 39.40) | 1.06 (1.02, 1.10) | 1.12 (1.08, 1.16) |
| nHDLox (normalized ratio) | 1.00 (0.96, 1.05) | 0.99 (0.95, 1.03) | 0.91 (0.87, 0.95) |
| LDL (mg/dl) | 89.70 (85.90, 93.60) | 1.03 (0.99, 1.07) | 1.05 (1.00, 1.10) |
| LDLox (U/L) | 48.13 (46.21, 50.12) | 1.11 (1.07, 1.15) | 1.11 (1.06, 1.16) |
| LDLox/LDL (U/100 ug) | 0.54 (0.52, 0.56) | 1.07 (1.03, 1.12) | 1.05 (1.00, 1.10) |
| Non-HDL (mg/dl) | 114.10 (110.20, 118.20) | 1.03 (1.00, 1.06) | 1.05 (1.01, 1.09) |
| Triglycerides (mg/dl) | 106.20 (99.40, 113.40) | 1.04 (0.98, 1.10) | 1.03 (0.97, 1.10) |